However, circulating ISM1 levels were lower in the middle-aged overweight population with type 2 diabetes than in the non-type-2-diabetic overweight group; this suggests that elevated ISM1 may reduce the risk of developing diabetes (J. Wang et al. 2022). This evidence concerns the gene ISM1 and diabetes mellitus.